Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV)

201377 citationsJournal Articlehybrid Open Access

Authors

Palonosetron is more effective than older 5HT3 RAs for controlling CINV in the delayed and overall postchemotherapy periods.

Good health and well-being

Published in: Supportive Care in Cancer

Volume 22, Issue 2, pp. 469-477

Field-Weighted Citation Impact: 8.73